83 related articles for article (PubMed ID: 2775839)
1. Ca2+ transport through lipid membrane by diastereomer cyclic octapeptides.
Kimura S; Ozeki E; Imanishi Y
Biopolymers; 1989 Jul; 28(7):1247-57. PubMed ID: 2775839
[TBL] [Abstract][Full Text] [Related]
2. Ca2+ binding cyclic octapeptides having an alternating Sar and a hydrophobic amino acid in the sequence.
Kimura S; Ozeki E; Imanishi Y
Biopolymers; 1989 Jul; 28(7):1235-46. PubMed ID: 2775838
[TBL] [Abstract][Full Text] [Related]
3. Cyclic hexapeptides bearing carboxyl groups. Interaction with metal ions and lipid membrane.
Ozeki E; Miyazu T; Kimura S; Imanishi Y
Int J Pept Protein Res; 1989 Aug; 34(2):97-103. PubMed ID: 2807735
[TBL] [Abstract][Full Text] [Related]
4. Structure investigation of amphiphilic cyclopeptides in isotropic and anisotropic environments-A model study simulating peptide-membrane interactions.
Koppitz M; Mathä B; Kessler H
J Pept Sci; 1999 Nov; 5(11):507-18. PubMed ID: 10587314
[TBL] [Abstract][Full Text] [Related]
5. Formation of several stable complexes between the minor components of the cyclic tetrapeptide cyclo-(-Pro1-Ala2-D-Phe3-Leu4-) and some specific Boc-amino acids.
McEwen I; Ottosson K
Biopolymers; 1993 Sep; 33(9):1377-87. PubMed ID: 8400032
[TBL] [Abstract][Full Text] [Related]
6. A cyclic CCK8 analogue selective for the cholecystokinin type A receptor: design, synthesis, NMR structure and binding measurements.
De Luca S; Ragone R; Bracco C; Digilio G; Aloj L; Tesauro D; Saviano M; Pedone C; Morelli G
Chembiochem; 2003 Nov; 4(11):1176-87. PubMed ID: 14613109
[TBL] [Abstract][Full Text] [Related]
7. Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.
Dutta AS; Crowther M; Gormley JJ; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Jamieson A; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
J Pept Sci; 2000 Jul; 6(7):321-41. PubMed ID: 10946997
[TBL] [Abstract][Full Text] [Related]
8. Homooligopeptides composed of hydrophobic amino acid residues interact in a specific manner by taking alpha-helix or beta-structure toward lipid bilayers.
Lee S; Yoshitomi H; Morikawa M; Ando S; Takiguchi H; Inoue T; Sugihara G
Biopolymers; 1995 Sep; 36(3):391-8. PubMed ID: 7669922
[TBL] [Abstract][Full Text] [Related]
9. Solid state structural analysis of the cyclooctapeptide cyclo- (Pro1-Pro-Phe-Phe-Ac6c-Ile-D-Ala-Val8).
Saviano M; Isernia C; Rossi F; Di Blasio B; Iacovino R; Mazzeo M; Pedone C; Benedetti E
Biopolymers; 2000 Feb; 53(2):189-99. PubMed ID: 10679623
[TBL] [Abstract][Full Text] [Related]
10. Conformation and complexation with metal ions of cyclic hexapeptides: cyclo (L-Leu-L-Phe-L-Pro)2 and cyclo [L-Cys(Acm)-L-Phe-L-Pro]2.
Ozeki E; Kimura S; Imanishi Y
Int J Pept Protein Res; 1989 Aug; 34(2):111-7. PubMed ID: 2807727
[TBL] [Abstract][Full Text] [Related]
11. Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers.
Rezai T; Yu B; Millhauser GL; Jacobson MP; Lokey RS
J Am Chem Soc; 2006 Mar; 128(8):2510-1. PubMed ID: 16492015
[TBL] [Abstract][Full Text] [Related]
12. Effects of amino acids and chirality for molecular folding of desoxazoline-ascidiacyclamide derivatives: X-ray crystal structures of four cyclic octapeptides including unusual amino acids, cyclo(-Ile-aThr-D-Val-Thz-)(2), cyclo(-Ala-aThr-D-Val-Thz-Ile-aThr-D-Val-Thz-), cyclo(-Val-aThr-D-Val-Thz-Ile-aThr-D-Val-Thz-), and cyclo(-Ile-aThr-Val-Thz-Ile-aThr-D-Val-Thz-).
Asano A; Doi M; Kobayashi K; Arimoto M; Ishida T; Katsuya Y; Mezaki Y; Hasegawa H; Nakai M; Sasaki M; Taniguchi T; Terashima A
Biopolymers; 2001 Mar; 58(3):295-304. PubMed ID: 11169389
[TBL] [Abstract][Full Text] [Related]
13. Beta2-amino acids in the design of conformationally homogeneous cyclo-peptide scaffolds.
Norgren AS; Büttner F; Prabpai S; Kongsaeree P; Arvidsson PI
J Org Chem; 2006 Sep; 71(18):6814-21. PubMed ID: 16930031
[TBL] [Abstract][Full Text] [Related]
14. Multiple conformational equilibria of cyclic octapeptide, cyclo (L-Pro-Sar)4 in solution.
Shimizu T; Tanaka Y; Tsuda K
Int J Pept Protein Res; 1983 Aug; 22(2):194-203. PubMed ID: 6618763
[TBL] [Abstract][Full Text] [Related]
15. Cyclic peptides. XIX. Synthesis, conformation, and biological activity of cyclo(-Pro-Val-Pro-Val-) with L-L-L-L and L-D-L-D sequences.
Ueda T; Sada I; Kato T; Izumiya N
Int J Pept Protein Res; 1985 May; 25(5):475-80. PubMed ID: 4019028
[TBL] [Abstract][Full Text] [Related]
16. Cyclic peptides. VIII. Synthesis and tryptic hydrolysis of cyclic depsidipeptides containing a lysine residue.
Yasutake A; Miyazaki K; Aoyagi H; Kato T; Izumiya N
Int J Pept Protein Res; 1980 Jul; 16(1):61-5. PubMed ID: 6777325
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity.
Matsoukas JM; Panagiotopoulos D; Keramida M; Mavromoustakos T; Yamdagni R; Wu Q; Moore GJ; Saifeddine M; Hollenberg MD
J Med Chem; 1996 Aug; 39(18):3585-91. PubMed ID: 8784457
[TBL] [Abstract][Full Text] [Related]
18. Conformational behaviour of a cyclolinopeptide A analogue: two-dimensional NMR study of cyclo(Pro1-Pro-Phe-Phe-Ac6c-Ile-ala-Val8).
Mazzeo M; Isernia C; Rossi F; Saviano M; Pedone C; Paolillo L; Benedetti E; Pavone V
J Pept Sci; 1995; 1(5):330-40. PubMed ID: 9223012
[TBL] [Abstract][Full Text] [Related]
19. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
Flouret G; Chaloin O; Borovickova L; Slaninová J
J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
[TBL] [Abstract][Full Text] [Related]
20. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
